A Phase 3, Multicenter, Randomized, Double Blind, Three-Arm Study to Evaluate the Efficacy and Safety of Tramadol Infusion (AVE-901) Versus Placebo in the Management of Postoperative Pain Following Bunionectomy
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Tramadol (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Avenue Therapeutics
- 27 Sep 2017 According to an Avenue Therapeutics media release, first patient has been dosed, and toplinn data expected in the second quarter of 2018.
- 19 Sep 2017 Status changed from planning to recruiting.
- 09 Aug 2017 According to a Fortress Biotech media release, Avenue Therapeutics (subsidiary of Fortress Biotech) is on track to initiate this trial in the third quarter of 2017.